Home » Funding Opportunities

Funding Opportunities

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more:

Request for Application Release and Peer Review Schedule
Financial Years 2012 & 2013

Commercialization Programs

Review Cycle	Award Mechanism Request for Application	RFA Release	Application Receipt	Application Review	Award Notification
Financial Year 2013 - Cycle 3 CLOSED	Company Commercialization Awards Revised: (05/16/2013) Instructions for Applicants The goal of the Company Commercialization Awards is to finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. Read more... The goal of the Company Commercialization Awards is to finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will provide companies or limited partnerships located and headquartered in Texas, or those that are willing to relocate to Texas, with the opportunity to further the development of new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. This award is intended to support companies that will be staffed with a majority of Texas-based employees, including C-level executives. Read less...	Nov 29, 2012	Dec 2012-Jan 2013	Continuous	Continuous
Financial Year 2013 - Cycle 3 CLOSED	Company Formation Awards Revised: (05/16/2013) Instructions for Applicants The goal of the Company Formation Awards is to finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. Read more... The goal of the Company Formation Awards is to finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will assist early-stage “start-up” companies by providing the opportunity to further the development of new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. This award mechanism will support companies that intend to undertake product research and development in Texas with a strong presence of Texas-based employees. In determining eligibility for this award, CPRIT will evaluate whether applicants have a significant presence in Texas or are willing to relocate to Texas. Read less...	Nov 29, 2012	Dec 2012-Jan 2013	Continuous	Continuous
Financial Year 2013 - Cycle 3 CLOSED	Company Relocation Awards Revised: (05/16/2013) Instructions for Applicants The goal of the Company Relocation Awards is to finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. Read more... The goal of the Company Relocation Awards is to finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will provide companies or limited partnerships that are willing to relocate to Texas with the opportunity to further the development of new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. This award mechanism will support companies that intend to undertake product research and development in Texas with a strong presence of Texas-based employees. Read less...	Nov 29, 2012	Dec 2012-Jan 2013	Continuous	Continuous
Financial Year 2012 - Cycle 2 CLOSED	Texas Life Science Incubator Infrastructure Awards Revised: (03/14/2012) Instructions for Applicants Revised: (03/14/2012) The goal of the Texas Life Sciences Incubator Infrastructure Award is the development or enhancement of incubator organizations that will provide valuable programs and services in Texas to enhance the ability to commercialize innovative, new products for the diagnosis, treatment, or prevention of cancer and to establish infrastructure that is critical to the development of a robust life sciences industry in the State. Read more... The goal of the Texas Life Sciences Incubator Infrastructure Award is the development or enhancement of incubator organizations that will provide valuable programs and services in Texas to enhance the ability to commercialize innovative, new products for the diagnosis, treatment, or prevention of cancer and to establish infrastructure that is critical to the development of a robust life sciences industry in the State. Supported incubator programs should promote a culture that rewards risk-taking and entrepreneurial projects, fosters collaboration and cooperation among different Texas institutions and organizations, and creates an environment of mentoring and shared experience and skills to foster the development of new entrepreneurs. This award is intended to support incubator organizations located in the State (with Texas-based employees) providing incubator services to Texas-based translational research projects and startup companies. Read less...	Sep 29, 2011	Oct 2011-Apr 2012	Apr-Jul 2012	Jul 2012

Research Programs

Review Cycle	Award Mechanism Request for Application	RFA Release	Application Receipt	Application Review	Award Notification
Financial Year 2013 - Cycle 1 CLOSED	High-Impact/High-Risk Research Awards (HIHR) Revised: (03/08/2012) Instructions for Applicants Supports relatively short-term high-impact/high-risk projects that are innovative, developmental, or exploratory in nature targeting new avenues of cancer research. Award: Up to $200,000 (total costs) for up to 2 years.	Feb 16, 2012	Apr 12- May 31, 2012	Sep-Oct 2012	Nov 2012
Financial Year 2013 - Cycle 1 CLOSED	Individual Investigator Research Awards (IIRA) Revised: (03/08/2012) Instructions for Applicants Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Competitive renewal applications accepted. RFA also includes a request for targeted applications for new CPRIT partnerships with The Carson Leslie Foundation and Hoffman-La Roche. Award: Up to $500,000 (total costs) for up to 3 years. Exceptions permitted if extremely well justified.	Feb 16, 2012	Apr 12- May 31, 2012	Sep-Oct 2012	Nov 2012
Financial Year 2013 - Cycle 1 CLOSED	Core Facility Support Awards (CFSA) Revised: (03/08/2012) Instructions for Applicants Supports the establishment or enhancement of core research facilities (laboratory based or clinical) that will provide valuable services to enhance the outcomes of scientifically meritorious cancer research projects. Award: Up to $2M (total costs) for the first year, and up to $1M (total costs) for subsequent years. Maximum duration of 5 years.	Feb 16, 2012	Apr 12- May 31, 2012	Sep-Oct 2012	Nov 2012
CLOSED	Recruitment of Investigators Performing Translational Research Revised: (10/04/2012) Supports investigators performing translational research who have the ability to make outstanding contributions to the field of cancer research. Candidates for this award may be at various stages of their career: newly independent investigators, rising stars, and established investigators. Award: 5 years, Up to $2 million for newly-independent investigators; Up to $4.5 million for rising stars; Up to $7.5 million for established investigators.	Sep 4, 2012	Dec 2012	Continuous	Continuous
CLOSED	Recruitment of Established Investigators Revised: (10/04/2012) Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas. Award: Up to $7.5M over a period of five years.	Sep 4, 2012	Dec 2012	Continuous	Continuous
CLOSED	Recruitment of First-Time, Tenure-Track Faculty Members Revised: (10/04/2012) Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research. Award: Up to $2 million over a period of 4 years.	Sep 4, 2012	Dec 2012	Continuous	Continuous
CLOSED	Recruitment of Clinical Investigators Revised: (10/04/2012) Supports investigators performing clinical research who will be or are making strong contributions to clinical cancer research. Candidates for this award may be at various stages of their career: newly independent investigators, rising stars, and established investigators. Award: 5 years, Up to $1 million for newly-independent investigators; Up to $2.5 million for rising stars; Up to $5 million for established investigators.	Sep 4, 2012	Dec 2012	Continuous	Continuous
CLOSED	Recruitment of Missing Links Revised: (10/04/2012) Recruits superb investigators who can fill special and specific needs as critically important members of collaborative research teams ("Missing Links"). Award: $500,000 to $2 million over a period of 4 years.	Sep 4, 2012	Dec 2012	Continuous	Continuous
CLOSED	Recruitment of Rising Stars Revised: (10/04/2012) Recruits outstanding early-stage investigators to Texas, who have demonstrated the promise for continued and enhanced contributions to the field of cancer research. Award: Up to $2.5 million over a period of 5 years.	Sep 4, 2012	Dec 2012	Continuous	Continuous
Financial Year 2012 - Cycle 2 CLOSED	Multi-Investigator Research Awards Instructions for Applicants Revised: (09/30/2011) Supports integrated programs of collaborative and cross-disciplinary cancer research among multiple investigators for projects that cannot be effectively addressed by an individual researcher or a group of researchers within the same discipline. Read more... Supports integrated programs of collaborative and cross-disciplinary cancer research among multiple investigators for projects that cannot be effectively addressed by an individual researcher or a group of researchers within the same discipline. A preapplication is required of those investigators submitting a new application. A letter of intent is required of those applicants preparing a resubmission. Award: 5 years, No limit set on the maximum amount that may be requested. Read less...	Aug 1, 2011	Sep 29- Nov 22, 2011	Feb-Mar 2012	Mar 2012
Financial Year 2012 - Cycle 2 CLOSED	Shared Instrumentation Awards Revised: (10/20/2011) Instructions for Applicants Revised: (10/20/2011) Supports the acquisition of major research instrumentation that cannot be requested through other CPRIT programs and whose purchase can be justified on a shared-use basis to support the goals of scientifically meritorious cancer research projects. Award: Up to $3 million in total costs for the first year; up to $300,000 per year for years 2-5.	Jul 7, 2011	Aug 4- Nov 22, 2011	Feb-Mar 2012	Mar 2012
Financial Year 2013 - Cycle 2 CLOSED	Bridging the Gap: Early Translational Research Awards Instructions for Applicants Supports projects that "bridge the gap" between promising new discoveries achieved in the research laboratory and commercial development for a therapeutic, device, or diagnostic assay through activities up to and including preclinical proof-of-principle data that demonstrate applicability to the planned clinical scenario. Award: Up to $1 million in total costs over a period of 1-3 years. Exceptions permitted if extremely well justified. Commercialization Plan	Nov 5, 2012	Nov 5- Dec 14, 2012	Feb 2013	Continuous

Prevention Programs

Review Cycle	Award Mechanism Request for Application	RFA Release	Application Receipt	Application Review	Award Notification
Financial Year 2013 - Cycle 1 CLOSED	Evidence-Based Cancer Prevention Services Revised: (07/17/2012) Instructions for Applicants This RFA solicits grant applications from qualified organizations located in the State of Texas that propose to deliver evidence-based services in at least one of the following cancer prevention and control areas: 1) Primary cancer prevention (e.g. vaccine-conferred immunity, tobacco cessation ... Read more... This RFA solicits grant applications from qualified organizations located in the State of Texas that propose to deliver evidence-based services in at least one of the following cancer prevention and control areas: 1) Primary cancer prevention (e.g. vaccine-conferred immunity, tobacco cessation); 2) Secondary prevention (e.g., screening/early detection for breast, cervical, and/or colorectal cancer); or 3) Tertiary prevention (e.g., survivorship services such as physical rehabilitation/therapy, psychosocial interventions, navigation services, palliative care). Comprehensive projects that include a continuum of services comprised of all or some of the following are preferred: Public and/or professional education and training, patient outreach, delivery of prevention and screening services, follow-up navigation, and survivorship services. Award: Up to $1.5 million in direct costs for up to 36 months. Read less...	May 31, 2012	Jun 21- Aug 28, 2012	Nov 2012	Jan 2013
Financial Year 2013 - Cycle 1 CLOSED	Cancer Prevention Microgrants Revised: (06/18/2012) Instructions for Applicants This RFA solicits grant applications from qualified organizations in the State of Texas that propose programs focusing on improving systems and removing barriers that will increase the delivery of primary preventive services for all cancers and/or screening services. Read more... This RFA solicits grant applications from qualified organizations in the State of Texas that propose programs focusing on improving systems and removing barriers that will increase the delivery of primary preventive services for all cancers and/or screening services. The purpose of this grant mechanism is to support organizations proposing evidence-based strategies in areas of the State that have populations with great need or high incidence and/or mortality rates, but lack the infrastructure to carry out prevention programs or services that are larger in scope. Award: Up to $150,000 in direct costs for up to 24 months Read less...	May 31, 2012	Jun 21- Aug 28, 2012	Nov 2012	Jan 2013
Financial Year 2013 - Cycle 1 CLOSED	Health Behavior Change Through Public Education Revised: (06/18/2012) Instructions for Applicants This RFA solicits grant applications from qualified organizations located in the State of Texas that propose health promotion, education, and outreach for prevention, early detection, and survivorship of cancer for the public that, ... Read more... This RFA solicits grant applications from qualified organizations located in the State of Texas that propose health promotion, education, and outreach for prevention, early detection, and survivorship of cancer for the public that, if successful, would increase the number of persons who improve their health behaviors related to the prevention of cancer, obtain recommended cancer screening tests, have cancers detected at earlier stages, and improve their quality of life if they are survivors of cancer. Award: Up to $300,000 in direct costs for up to 36 months Read less...	May 31, 2012	Jun 21- Aug 28, 2012	Nov 2012	Jan 2013